Dr. Vijayalakshmi Periyasamy | Bioinformatics | Best Researcher Award

Assistant Professor AT Holy Cross College, India

Dr. P. Vijayalakshmi is an Assistant Professor at the Department of Biotechnology & Bioinformatics, Holy Cross College, Trichy. She holds a Ph.D. in Biotechnology from Bharathidasan University and specializes in drug discovery using machine learning, molecular modeling, and computer-aided drug design. With over 59 publications, a citation count of 1207, an H-index of 12, and an i10 index of 13, Dr. Vijayalakshmi has made significant contributions to antibacterial and anticancer drug discovery. Her work also includes toxicological research using animal models, as well as molecular insights into cancer therapies.

professional profile

Scopus Profile

Google Scholar

Education

Dr. Vijayalakshmi holds a Ph.D. in Biotechnology (2015) from Bharathidasan University, Tiruchirappalli, with her research focusing on in silico and in vitro drug design targeting Staphylococcus aureus DNA. Her work received high commendation, emphasizing her proficiency in computational biology and biotechnology. Prior to this, she completed her M.Sc. in Bioinformatics (2009) and B.Sc. in Zoology (2007) from Holy Cross College, Tiruchirappalli. Her academic foundation has equipped her with interdisciplinary expertise in bioinformatics, molecular biology, and biotechnology, which she has effectively applied to her research on drug discovery. Dr. Vijayalakshmi’s education has been a strong pillar in her pursuit of molecular modeling, computational drug design, and the development of innovative therapeutic solutions for cancer and bacterial diseases.

work Experience

Dr. P. Vijayalakshmi is currently serving as an Assistant Professor in the Department of Biotechnology & Bioinformatics at Holy Cross College, Trichy, since August 2022. Before her teaching career, she worked extensively in research roles, contributing to prestigious projects. She served as a Research Associate at the DBT-BIF Centre, Holy Cross College, from 2011 to 2021, where she developed computational models for drug discovery. Her research experience also includes a stint as a Project Assistant at Alagappa University under Dr. J. Jeyakanthan, focusing on molecular modeling and bioinformatics tools in drug design. With her profound background in computational biology and biotechnology, Dr. Vijayalakshmi has a unique blend of academic and research expertise, making significant contributions to the field of antibacterial and anticancer drug discovery.

Research Focus

Dr. P. Vijayalakshmi’s research focus lies at the intersection of computational biology and drug discovery. Her primary areas of expertise include machine learning applications in drug discovery, molecular modeling, and computer-aided drug design (CADD). She has made significant advancements in antibacterial and anticancer drug discovery, exploring novel inhibitors for pathogens such as Staphylococcus aureus and investigating the therapeutic potential of compounds like piperine and quercetin. Her recent research projects include exploring estrogen receptors for glioblastoma therapy and analyzing the toxicological properties of Himantura imbricata venom using zebrafish models. Dr. Vijayalakshmi’s interdisciplinary approach, combining molecular biology with bioinformatics and computational modeling, makes her a leading researcher in designing novel therapeutic solutions, with particular emphasis on cancer and bacterial infections.

Awards and honors

Dr. P. Vijayalakshmi has been recognized for her outstanding contributions to biotechnology and bioinformatics. Her research on in silico and in vitro approaches targeting DNA inhibitors of Staphylococcus aureus during her Ph.D. was highly commended. Throughout her career, she has received accolades for her innovative work in molecular modeling and computational drug design. Her papers have consistently been published in high-impact journals, reflecting her contributions to antibacterial and anticancer research. Additionally, her collaborative work in advancing machine learning applications in drug discovery has been well-regarded by the academic community. Though specific awards and honors were not listed, her substantial citation count, impressive H-index, and leading roles in published research reflect her influence and impact in the biotechnology field.

Conclusion

Dr. Vijayalakshmi’s extensive research output, interdisciplinary expertise, and impactful contributions to drug discovery make her a strong candidate for the Best Researcher Award. While strengthening her profile in terms of grant acquisition and international collaborations would be beneficial, her current body of work demonstrates significant potential to be recognized with this prestigious award.

Publications to Noted

Unlocking estrogen receptor: Structural insights into agonists and antagonists for glioblastoma therapy
Authors: Madeshwaran A., Vijayalakshmi P., Umapathy V.R., Shanmugam R., Selvaraj C.
Citations: 0
Year: 2024

Evaluation of the toxicological properties of Himantura imbricata Venom using a zebrafish model (Danio rerio)
Authors: Selvaraj U., Ganapathy S., Muthuvel A., Masood Khan J., Vijayalakshmi P.
Citations: 0
Year: 2024

Metalloproteins structural and functional insights into immunological patterns
Authors: Selvaraj C., Vijayalakshmi P., Alex A.M., Vijayakumar R., Umapathy V.R.
Citations: 0
Year: 2024

Genomics an assets of precision medicine in oral oncology
Authors: Gowdham M., Vijayalakshmi P.
Citations: 0
Year: 2024

Exploring the enigmatic influence of miR-155 in oral squamous cell carcinoma: An odyssey from molecular maneuvers to therapeutic prospects
Authors: Manivel G., Periyasamy V.
Citations: 0
Year: 2024

Octyl Gallate and Gallic Acid Isolated from Terminalia bellirica Circumvent Breast Cancer Progression by Enhancing the Intrinsic Apoptotic Signaling Pathway and Elevating the Levels of Anti-oxidant Enzymes
Authors: Vijayalakshmi P., Indu S., Ireen C., Manjunathan R., Rajalakshmi M.
Citations: 1
Year: 2023

Hypoglycemic Potential of Carica papaya in Liver Is Mediated through IRS-2/PI3K/SREBP-1c/GLUT2 Signaling in High-Fat-Diet-Induced Type-2 Diabetic Male Rats
Authors: Roy J.R., Janaki C.S., Jayaraman S., Bhuvaneswari P., Swetha P.
Citations: 8
Year: 2023

Carica Papaya Reduces High Fat Diet and Streptozotocin-Induced Development of Inflammation in Adipocyte via IL-1β/IL-6/TNF-α Mediated Signaling Mechanisms in Type-2 Diabetic Rats
Authors: Rebecca Roy J., Janaki C.S., Jayaraman S., Krishnamoorthy K., Prasad M.
Citations: 6
Year: 2023

Identification of potential inhibitor(s) against phospholipase A2 using a network pharmacology-based approach
Authors: Rajalakshmi M., Vijayalakshmi P., Indu S.
Citations: 0
Year: 2023

Therapeutic mode of action of synthetic compounds and phytochemicals in the molecular mechanisms of phospholipases with respect to cancer
Authors: Rajalakshmi M., Indu S., Vijayalakshmi P.
Citations: 0
Year: 2023

Vijayalakshmi Periyasamy | Bioinformatics | Best Researcher Award